Liver Cancer Surgery in China: Successful Resection in a 90-Year-Old Patient

For families searching for liver cancer surgery in China, the question of age often looms large: is my loved one too old for a major operation? A recent report from Fudan University Shanghai Cancer Center offers a compelling answer, detailing the successful surgical treatment of a 90-year-old patient with liver cancer.

Liver Cancer Surgery in China: A Case That Challenges Age Limits

On May 14, 2026, Shanghai-based news outlet Kankanews featured a segment on its program “Nightline Appointment” titled “A 90-Year-Old Liver Cancer Patient, Why Dare to Undergo This Surgery?” The report highlighted the clinical decision-making and surgical care provided to an elderly patient, challenging conventional assumptions about age and surgical eligibility in oncology.

The case centered on a nonagenarian diagnosed with hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Typically, advanced age is considered a relative contraindication for major abdominal surgery due to concerns about frailty, reduced organ reserve, and postoperative complications. However, the medical team at Fudan University Shanghai Cancer Center proceeded with a curative-intent liver resection after a comprehensive multidisciplinary evaluation.

Why Age Alone Is Not a Barrier

The report emphasized that the decision to operate was not based on chronological age but on the patient’s biological condition. Key factors assessed included the patient’s performance status, liver function reserve, tumor characteristics, and absence of significant comorbidities. This approach aligns with global guidelines from organizations like the National Comprehensive Cancer Network (NCCN), which recommend individualized treatment planning for elderly cancer patients.

The surgical team utilized precise preoperative imaging and intraoperative techniques to minimize blood loss and preserve healthy liver parenchyma. While specific surgical details were not fully disclosed in the broadcast, the successful outcome demonstrates that with meticulous planning, even patients in their tenth decade of life can safely undergo complex oncologic procedures.

Multidisciplinary Care as the Foundation

A critical factor highlighted in the news segment was the role of multidisciplinary team (MDT) collaboration. The patient’s case was reviewed by hepatobiliary surgeons, anesthesiologists, medical oncologists, and geriatric specialists. This collaborative model is standard practice at leading Chinese cancer centers and is increasingly recognized as essential for managing high-risk surgical candidates.

The report also touched on the importance of postoperative recovery protocols, including enhanced recovery after surgery (ERAS) pathways, which have been shown to reduce complications and shorten hospital stays. For elderly patients, these protocols are particularly valuable in maintaining functional independence after surgery.

While this single case does not constitute a clinical trial, it adds to a growing body of evidence that carefully selected elderly patients can benefit from curative treatments for liver cancer. Research published in journals such as PubMed supports the notion that age alone should not exclude patients from potentially life-saving surgery.

For international patients, this case underscores the advanced surgical capabilities and patient-centered approach available at major Chinese oncology centers. The willingness to evaluate each patient individually, rather than applying rigid age cutoffs, reflects a sophisticated standard of care.

While this specific procedure was performed at a top-tier cancer hospital, the underlying principle—that age is not an absolute barrier to surgery—is increasingly reflected across China’s leading medical institutions. For families considering liver cancer treatment abroad, this means that a thorough, individualized assessment may open doors that seemed closed elsewhere.

What This Means for Patients

For older adults diagnosed with liver cancer, this case offers hope that curative surgery may still be an option, provided they are in otherwise good health. China as a medical destination is becoming known for its willingness to tackle complex cases through careful, multidisciplinary evaluation. Families exploring safe surgery in China should seek hospitals with established MDT programs and experience in geriatric oncology. Ultimately, a comprehensive pre-surgical assessment—not age alone—should guide treatment decisions.

Source: 复旦大学附属肿瘤医院

Reviewed by ToChinaMed. Published: 2026-05-14. This article is based on publicly available medical news and is not a substitute for professional medical advice.

ToChinaMed helps international patients find reliable medical treatment in China.